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The authors of the above-cited article request its retraction. The authors have reported that some of the findings and conclusions of the article cannot be relied upon. Specifically, the original data behind Figures 1, 2, 3, 6B, and 6C could not be located and the results could not be replicated. However, the other findings regarding the antiviral and anti-tumoral effect of the synthetic RIG-I ligands still hold true.

The corresponding authors take full responsibility for a failure to follow proper quality control over the production, validation and dissemination of that data. All authors agree with this request and the information provided in this notice.

The Editors commend the authors for being forthcoming and disclosing this issue.
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